Expanding the donor pool for lung transplantation using HCV-positive donors

Hrishikesh S. Kulkarni, Kevin M. Korenblat, Daniel Kreisel


Despite the increasing numbers of heart and lung transplants within the United States and worldwide and an increased awareness regarding organ donation, there remains a global shortage of donor organs. As a result, the waitlist mortality rate for lung transplantation is approximately 15.3% for all diagnoses in the United States despite introduction of the lung allocation score (1,2), and is higher among those patients listed in areas of low local lung availability (3).